Literature contribution is necessary for oligometastatic disease definition to clarify its nature and compare treatment options.
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Isolated pulmonary metastasis is observed in 2%-3% of prostate cancer cases but a complete treatment algorithm was not established for these patients.
📊
Temel Bulgular & Veri:This study aimed to present a case of isolated pulmonary metastasis during the follow-up after radical prostatectomy, in which recurrence was not detected for 2 years after metastasectomy.
💡
Sonuç & Katkı:Literature contribution is necessary for oligometastatic disease definition to clarify its nature and compare treatment options.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Abstract
Isolated pulmonary metastasis is observed in 2%-3% of prostate cancer cases but a complete treatment algorithm was not established for these patients. This study aimed to present a case of isolated pulmonary metastasis during the follow-up after radical prostatectomy, in which recurrence was not detected for 2 years after metastasectomy. The patient was on follow-up without any treatment for 22 months, with an unobservable prostate-specific antigen value. Metastasectomy in oligometastatic disease has emerged as a treatment option in recent years but is not considered a standard treatment. Literature contribution is necessary for oligometastatic disease definition to clarify its nature and compare treatment options.
🔖
Bu Makaleye Atıf Yap
Gemalmaz, H., Çulhacı, N., Akdağ, A., Dündar, M. (2022). Isolated Pulmonary Metastasis Metastasectomy After Curative Prostate Cancer Treatment in Oligometastatic Disease. Üroonkoloji Bülteni, Cilt: 20 - Sayı: 4, 270–272. https://ajindex.com/articles/645722
Gandaglia G, Abdollah F, Schiffmann J, et al. Distribution of metastatic sites in patients with prostate cancer: a population-based analysis. Prostate 2014;74:210-216
Gandaglia G, Karakiewicz PI, Briganti A, et al. Impact of the site of metastases on survival in patients with metastatic prostate cancer. Eur Urol 2015;68:325-334
Große Hokamp N, Kobe C, Linzenich E, et al. Solitary PSMA-positive pulmonary metastasis in biochemical relapse of prostate cancer. Clin Nucl Med 2017;42:406-407
Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev 1989;8:98-101
Jacob K, Webber M, Benayahu D, et al. Osteonectin promotes prostate cancer cell migration and invasion: A possible mechanism for metastasis to bone. Cancer Res 1999;59:4453-4457
Batson OV. The function of the vertebral veins and their role in the spread of metastases. Ann Surg 1940;112:138-149
Briganti A, Suardi N, Capogrosso P, et al. Lymphatic spread of nodal metastases in high-risk prostate cancer: the ascending pathway from the pelvis to the retroperitoneum. Prostate 2012;72:186-192
Bubendorf L, Schopfer A, Wagner U, et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol 2000;31:578-583
Abalde-Cela S, Piairo P, Diéguez L. The significance of circulating tumour cells in the clinic. Acta Cytol 2019;63:466-478
Celia-Terrassa T, Kang Y. Metastatic niche functions and therapeutic opportunities Nat Cell Biol 2018;20:868-877
Gundem G, Van Loo P, Kremeyer B, et al. The evolutionary history of lethal metastatic prostate cancer. Nature 2015;520:353-357. 12. van den Bergh RC, van Casteren NJ, van den Broeck T, et al. Role of hormonal treatment in prostate cancer patients with nonmetastatic disease recurrence after local curative treatment: a systematic review. Eur Urol 2016;69:802-820
Battaglia A, De Meerleer G, Tosco L, et al. Novel insights into the management of oligometastatic prostate cancer: a comprehensive review. Eur Urol Oncol 2019;2:174-188
Ost P, Reynders D, Decaestecker K, et al. Surveillance or metastasisdirected therapy for oligometastatic prostate cancer recurrence: a prospective, randomized, multicenter phase II trial. J Clin Oncol 2018;36:446-453
Gago JP, Câmara G, Dionísio J, et al. Pulmonary metastasis as sole manifestation of relapse in previously treated localised prostate canc